High Levels of Autoantibodies to HSP47 in Nonspecific Interstitial Pneumonia
Author Information
Author(s): Kakugawa Tomoyuki, Yokota Shin-ichi, Mukae Hiroshi, Kubota Hiroshi, Sakamoto Noriho, Mizunoe Syunji, Matsuoka Yasuhiro, Kadota Jun-ichi, Fujii Nobuhiro, Nagata Kazuhiro, Kohno Shigeru
Primary Institution: Nagasaki University School of Medicine
Hypothesis
Are autoantibody titers to HSP47 different in idiopathic UIP, idiopathic NSIP, COP, and healthy subjects?
Conclusion
High levels of anti-HSP47 autoantibody titers were found in patients with idiopathic fibrosing NSIP compared to other IIPs and healthy volunteers.
Supporting Evidence
- Patients with idiopathic NSIP had significantly higher autoantibody titers than those with IPF and healthy volunteers.
- The study included a total of 56 participants, with 38 patients and 18 healthy volunteers.
- The findings suggest that anti-HSP47 autoantibody titers may help differentiate between types of interstitial pneumonia.
Takeaway
This study found that people with a specific lung disease called idiopathic fibrosing NSIP have more antibodies against a protein called HSP47 than those with other lung diseases or healthy people.
Methodology
Serum levels of autoantibodies to HSP47 were measured in patients with various forms of interstitial pneumonia and healthy volunteers using ELISA.
Potential Biases
The study was retrospective and excluded patients diagnosed only clinically, which may introduce selection bias.
Limitations
The study included a relatively small number of patients and may not represent the general patient population with interstitial pneumonia.
Participant Demographics
Patients included 16 with idiopathic pulmonary fibrosis, 15 with idiopathic NSIP, 7 with cryptogenic organizing pneumonia, and 18 healthy volunteers.
Statistical Information
P-Value
p<0.01 for NSIP vs IPF
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website